Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis

M Perera; N Papa; M Roberts; M Williams; C Udovicich; I Vela; D Christidis; D Bolton; MS Hofman; N Lawrentschuk; DG Murphy

Journal article

Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis

M Perera, N Papa, M Roberts, M Williams, C Udovicich, I Vela, D Christidis, D Bolton, MS Hofman, N Lawrentschuk, DG Murphy

European Urology | ELSEVIER | Published : 2020

DOI: 10.1016/j.eururo.2019.01.049

Abstract

Gallium-68 prostate-specific membrane antigen positron emission tomography is now an established imaging technique that has been developed in response to inadequacies in standard-of-care imaging modalities to improve the detection of metastatic disease in prostate cancer. In light of the growing body of evidence, we summarised the data to date to provide clinicians with an overview of this imaging modality.

University of Melbourne Researchers

Damien Bolton Author

Michael Hofman Author

Nathan Lawrentschuk Author

Declan Murphy Author

Grants

Funding Acknowledgements

Marlon Perera is supported by a Royal Australasian College of Surgeons Scholarship. Ian Vela is funded by a Movember Clinician Scientist Award awarded through Prostate Cancer Foundation of Australia's Research Program.